1. Home
  2. MDXH vs QUIK Comparison

MDXH vs QUIK Comparison

Compare MDXH & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • QUIK
  • Stock Information
  • Founded
  • MDXH 2003
  • QUIK 1988
  • Country
  • MDXH Belgium
  • QUIK United States
  • Employees
  • MDXH N/A
  • QUIK N/A
  • Industry
  • MDXH
  • QUIK Semiconductors
  • Sector
  • MDXH
  • QUIK Technology
  • Exchange
  • MDXH Nasdaq
  • QUIK Nasdaq
  • Market Cap
  • MDXH 84.6M
  • QUIK 87.3M
  • IPO Year
  • MDXH 2021
  • QUIK 1997
  • Fundamental
  • Price
  • MDXH $2.30
  • QUIK $6.04
  • Analyst Decision
  • MDXH Buy
  • QUIK Strong Buy
  • Analyst Count
  • MDXH 1
  • QUIK 3
  • Target Price
  • MDXH $6.00
  • QUIK $10.87
  • AVG Volume (30 Days)
  • MDXH 70.5K
  • QUIK 264.6K
  • Earning Date
  • MDXH 08-20-2025
  • QUIK 08-12-2025
  • Dividend Yield
  • MDXH N/A
  • QUIK N/A
  • EPS Growth
  • MDXH N/A
  • QUIK N/A
  • EPS
  • MDXH N/A
  • QUIK N/A
  • Revenue
  • MDXH $94,507,000.00
  • QUIK $18,768,000.00
  • Revenue This Year
  • MDXH $23.51
  • QUIK $11.58
  • Revenue Next Year
  • MDXH $17.68
  • QUIK $40.23
  • P/E Ratio
  • MDXH N/A
  • QUIK N/A
  • Revenue Growth
  • MDXH 25.46
  • QUIK N/A
  • 52 Week Low
  • MDXH $1.35
  • QUIK $4.26
  • 52 Week High
  • MDXH $3.50
  • QUIK $13.36
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 58.21
  • QUIK 60.07
  • Support Level
  • MDXH $1.90
  • QUIK $5.81
  • Resistance Level
  • MDXH $2.21
  • QUIK $6.70
  • Average True Range (ATR)
  • MDXH 0.12
  • QUIK 0.35
  • MACD
  • MDXH 0.00
  • QUIK 0.04
  • Stochastic Oscillator
  • MDXH 82.35
  • QUIK 61.74

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About QUIK QuickLogic Corporation

QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.

Share on Social Networks: